These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38478027)

  • 1. Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis.
    Chai MG; Tu Q; Cotta MO; Bauer MJ; Balch R; Okafor C; Comans T; Kruger P; Meyer J; Shekar K; Brady K; Fourie C; Sharp N; Vlad L; Whiley D; Ungerer JPJ; Mcwhinney BC; Farkas A; Paterson DL; Clark JE; Hajkowicz K; Raman S; Bialasiewicz S; Lipman J; Forde BM; Harris PNA; Schlapbach LJ; Coin L; Roberts JA; Irwin AD
    Intensive Care Med; 2024 Apr; 50(4):539-547. PubMed ID: 38478027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency of dosing software using Bayesian forecasting in achieving target antibiotic exposures in critically ill patients, a prospective cohort study.
    Chai MG; Roberts JA; Kelly CF; Ungerer JPJ; McWhinney BC; Lipman J; Farkas A; Cotta MO
    Anaesth Crit Care Pain Med; 2023 Dec; 42(6):101296. PubMed ID: 37579945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising Treatment Outcomes for Children and Adults Through Rapid Genome Sequencing of Sepsis Pathogens. A Study Protocol for a Prospective, Multi-Centre Trial (DIRECT).
    Irwin AD; Coin LJM; Harris PNA; Cotta MO; Bauer MJ; Buckley C; Balch R; Kruger P; Meyer J; Shekar K; Brady K; Fourie C; Sharp N; Vlad L; Whiley D; Beatson SA; Forde BM; Paterson D; Clark J; Hajkowicz K; Raman S; Bialasiewicz S; Lipman J; Schlapbach LJ; Roberts JA
    Front Cell Infect Microbiol; 2021; 11():667680. PubMed ID: 34249774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional study.
    Fleuren LM; Roggeveen LF; Guo T; Waldauf P; van der Voort PHJ; Bosman RJ; Swart EL; Girbes ARJ; Elbers PWG
    Crit Care; 2019 May; 23(1):185. PubMed ID: 31118061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.
    Abdul-Aziz MH; Sulaiman H; Mat-Nor MB; Rai V; Wong KK; Hasan MS; Abd Rahman AN; Jamal JA; Wallis SC; Lipman J; Staatz CE; Roberts JA
    Intensive Care Med; 2016 Oct; 42(10):1535-1545. PubMed ID: 26754759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of a precision dosing software program for predicting antibiotic concentrations in critically ill patients.
    Chai MG; Roberts JA; Farkas A; Cotta MO
    J Antimicrob Chemother; 2023 Feb; 78(2):354-358. PubMed ID: 36454242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trial.
    Roggeveen LF; Guo T; Fleuren LM; Driessen R; Thoral P; van Hest RM; Mathot RAA; Swart EL; de Grooth HJ; van den Bogaard B; Girbes ARJ; Bosman RJ; Elbers PWG
    Crit Care; 2022 Sep; 26(1):265. PubMed ID: 36064438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic parameters over time during sepsis and the association of target attainment and outcomes in critically ill children and young adults receiving ceftriaxone.
    Tang Girdwood S; Tang P; Fenchel M; Dong M; Stoneman E; Jones R; Ostermeier A; Curry C; Forton M; Hail T; Mullaney R; Diseroad E; Punt N; Kaplan J; Vinks AA
    Pharmacotherapy; 2023 Jul; 43(7):609-621. PubMed ID: 36727212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cumulative fluid balance on the pharmacokinetics of extended infusion meropenem in critically ill patients with sepsis.
    Pařízková RČ; Martínková J; Havel E; Šafránek P; Kaška M; Astapenko D; Bezouška J; Chládek J; Černý V
    Crit Care; 2021 Jul; 25(1):251. PubMed ID: 34274013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
    Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III.
    Lipman J; Brett SJ; De Waele JJ; Cotta MO; Davis JS; Finfer S; Glass P; Knowles S; McGuinness S; Myburgh J; Paterson DL; Peake S; Rajbhandari D; Rhodes A; Roberts JA; Shirwadkar C; Starr T; Taylor C; Billot L; Dulhunty JM
    Crit Care Resusc; 2019 Mar; 21(1):63-68. PubMed ID: 30857514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncertainty in Antibiotic Dosing in Critically Ill Neonate and Pediatric Patients: Can Microsampling Provide the Answers?
    Dorofaeff T; Bandini RM; Lipman J; Ballot DE; Roberts JA; Parker SL
    Clin Ther; 2016 Sep; 38(9):1961-75. PubMed ID: 27544661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.
    Li J; Udy AA; Kirkpatrick CM; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2012 Jan; 39(1):69-72. PubMed ID: 22024354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Diagnostic Stewardship for Blood Cultures in Critically Ill Children With Culture Rates, Antibiotic Use, and Patient Outcomes: Results of the Bright STAR Collaborative.
    Woods-Hill CZ; Colantuoni EA; Koontz DW; Voskertchian A; Xie A; Thurm C; Miller MR; Fackler JC; Milstone AM; ; Agulnik A; Albert JE; Auth MJ; Bradley E; Clayton JA; Coffin SE; Dallefeld S; Ezetendu CP; Fainberg NA; Flaherty BF; Foster CB; Hauger SB; Hong SJ; Hysmith ND; Kirby AL; Kociolek LK; Larsen GY; Lin JC; Linam WM; Newland JG; Nolt D; Priebe GP; Sandora TJ; Schwenk HT; Smith CM; Steffen KM; Tadphale SD; Toltzis P; Wolf J; Zerr DM
    JAMA Pediatr; 2022 Jul; 176(7):690-698. PubMed ID: 35499841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
    Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A personalised approach to antibiotic pharmacokinetics and pharmacodynamics in critically ill patients.
    Heffernan AJ; Mohd Sazlly Lim S; Lipman J; Roberts JA
    Anaesth Crit Care Pain Med; 2021 Dec; 40(6):100970. PubMed ID: 34728411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial.
    Ewoldt TMJ; Abdulla A; Rietdijk WJR; Muller AE; de Winter BCM; Hunfeld NGM; Purmer IM; van Vliet P; Wils EJ; Haringman J; Draisma A; Rijpstra TA; Karakus A; Gommers D; Endeman H; Koch BCP
    Intensive Care Med; 2022 Dec; 48(12):1760-1771. PubMed ID: 36350354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients.
    De Waele JJ; Lipman J; Akova M; Bassetti M; Dimopoulos G; Kaukonen M; Koulenti D; Martin C; Montravers P; Rello J; Rhodes A; Udy AA; Starr T; Wallis SC; Roberts JA
    Intensive Care Med; 2014 Sep; 40(9):1340-51. PubMed ID: 25053248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.
    Warttig S; Alderson P; Evans DJ; Lewis SR; Kourbeti IS; Smith AF
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012404. PubMed ID: 29938790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.